Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Receives Consensus Rating of “Moderate Buy” from Analysts

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) have earned an average rating of “Moderate Buy” from the six analysts that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $24.25.

A number of research analysts have recently commented on ANL shares. Cantor Fitzgerald started coverage on shares of Adlai Nortye in a report on Monday, June 22nd. They issued an “overweight” rating on the stock. Leerink Partners assumed coverage on shares of Adlai Nortye in a research note on Friday, March 20th. They issued an “outperform” rating and a $23.00 price objective for the company. JonesTrading assumed coverage on shares of Adlai Nortye in a research report on Thursday, May 14th. They set a “buy” rating and a $22.00 price target for the company. Wall Street Zen raised shares of Adlai Nortye to a “hold” rating in a research report on Saturday, March 7th. Finally, HC Wainwright increased their price objective on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a research report on Monday, April 20th.

Adlai Nortye Stock Performance

ANL stock opened at $10.00 on Monday. Adlai Nortye has a twelve month low of $0.88 and a twelve month high of $17.25. The firm’s fifty day simple moving average is $12.25 and its two-hundred day simple moving average is $8.29.

Hedge Funds Weigh In On Adlai Nortye

Several hedge funds and other institutional investors have recently bought and sold shares of the business. SmartHarvest Portfolios LLC increased its holdings in Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after buying an additional 1,279 shares during the period. Renaissance Technologies LLC acquired a new stake in Adlai Nortye in the 1st quarter valued at $457,000. ADAR1 Capital Management LLC acquired a new stake in Adlai Nortye in the 1st quarter valued at $816,000. Finally, Affinity Asset Advisors LLC acquired a new stake in Adlai Nortye in the 1st quarter valued at $1,140,000. Institutional investors and hedge funds own 35.21% of the company’s stock.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.